Drug intelligence / Profile preview

EMP + MOM

Development stage
Phase 3
Lead developer
Betalin Therapeutics
Modality
Stem Cell Therapies → Cell Therapies
Administration
Surgical Implantation
01

Overview

EMP + MOM is an implantable cell-based regenerative therapy developed by Betalin Therapeutics for the treatment of Type 1 diabetes. The technology integrates an Engineered Micro-Pancreas (EMP) with a proprietary Micro-Organ Matrix (MOM), a biological scaffold that mimics the natural extracellular environment of the pancreas. This matrix supports the survival, vascularization, and long-term function of either harvested pancreatic islets or stem cell-derived beta cells. Once surgically implanted, the device functions as an autonomous artificial organ, sensing blood glucose levels and secreting regulated amounts of insulin to restore glycemic control and potentially eliminate the need for exogenous insulin injections. The MOM component is specifically designed to provide the necessary nutrients and growth factors to maintain the viability of the insulin-producing cells within the device.

Other names
Engineered Micro-PancreasMicro-Organ MatrixMicro-Organ Membrane
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on EMP + MOM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EMP + MOM.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call